Mural Oncology Plc MURA

$2.04 0.00 (—)

Valuation

Market cap
35,382,000
Revenue TTM
$0
Net income TTM
$-128,510,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
127,700
Avg volume
168,684
Day's range
$2.03 – $2.04
Shares out
17,344,000
Stochastic %K
25%
Beta
2.93
Analysts
Hold
Price target
$13.00

Price

Company profile

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and a...

Show more

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.

Industry
Biotechnology
Sector
Healthcare
Phone
353 1 905 8020
Website
https://www.muraloncology.com
Address
10 Earlsfort Terrace, Dublin, Ireland

Latest news

Stocktwits

Azlvr Dec 19, 6:38 PM
$MURA Review Alejos here. 🫨 https://www.trustpilot.com/review/www.jccapitalconsultants.com
0 replies
TwongStocks Dec 5, 1:00 PM
$MURA Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition https://www.globenewswire.com/news-release/2025/12/05/3200635/0/en/Mural-Oncology-Announces-Effectiveness-of-Scheme-of-Arrangement-and-Completion-of-Acquisition.html
0 replies
TwongStocks Dec 3, 10:00 PM
$MURA Announces Sanction of the Scheme by the High Court https://www.globenewswire.com/news-release/2025/12/03/3199385/0/en/Mural-Oncology-Announces-Sanction-of-the-Scheme-by-the-High-Court.html Delivery of the Court Order to the Irish Registrar of Companies is expected to occur, and the Acquisition is expected to become effective, on 5 December 2025 (the “Effective Date”). Accordingly, 4 December 2025 is expected to be the last date on which trading of Mural Shares on the Nasdaq will occur. Cancellation of the admission of Mural Shares to trading on the Nasdaq Global Market is expected to occur with effect from 8.00 pm (U.S. Eastern Time) on 4 December 2025.
0 replies
TwongStocks Dec 2, 8:40 PM
$MURA NASDAQ Equity Corporate Actions Alert # 2025 - 646 (UPDATED: Anticipated Last Trade Date) Information Regarding the Merger of Mural Oncology plc (MURA) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2025-646 At a special meeting held on October 24, 2025, the shareholders of Mural Oncology plc (MURA) approved the proposed merger with XOMA Royalty Corporation (XOMA). The merger is tentatively scheduled to close prior to the market open on December 5, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on December 4, 2025. If the merger closes as anticipated, the stock will remain halted on the day of closing (December 5th) and will be suspended effective December 8, 2025.
0 replies
Mergerbrief Oct 24, 11:56 AM
$MURA / $XOMA - Shareholder Vote $MURA MergerBrief.com For Full Schedule
0 replies
NVDAMillionaire Sep 9, 9:24 AM
$MURA Excellent article that nails exactly where MURA stands right now. So if you want to update your MURA knowledge or get acquainted with MURA, this is a must read. https://beyondspx.com/quote/MURA/analysis/mural-oncology-a-biotech-pivot-amidst-trial-setbacks-and-strategic-uncertainty-nasdaq-mura
0 replies
Raxothus Aug 21, 6:44 PM
EOD FOLLOW-UP - 08/20/25 Tracking continuation watchlist from today based on intraday highs vs. close ❌ $CLNN - Closed 5.66, HOD 5.59 (–1.2%) Failed to push, straight fade. ❌ $MURA - No volume, no movement. ❌ $COCH - No volume, no movement. ✅ $NESR - Closed 8.31, HOD 8.81 (+6.0%) Brief pop, then dancing around the VWAP ❌ $GES - No volume, no movement. Recap: 5 total, 1 winners, 4 fails → 20% accuracy Almost no continuation strength today. $NESR gave a small pop but couldn’t hold, while $CLNN, $MURA, $COCH, and $GES showed no traction. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 replies
Sswerve Aug 20, 7:47 PM
$MURA Congrats to the clowns who bought this over $2 . You are the proud new owners of $XOMA another failed biotech that’s down 99% since IPO. 😂🤣🤣. Tried to warn you clowns you were falling for an Irish scam. Closed out my short last week , just had to rub it in for the dudes who were calling me low IQ and retarded🤡🤡
1 replies